UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~March~~May 916, ~~2022~~2024

Intorio, Corp.

(Exact name of registrant as specified in its charter)

Nevada

(State or other jurisdiction
of incorporation)

333-255055
(Commission
File Number)

98-1578603
(IRS Employer
Identification No.)

~~24 Alexander Kazbegi~~17875 ~~Ave,~~Von ~~Tbilisi~~Karman ~~0177~~Avenue, ~~Georgia~~

~~(Address~~Irvine, ofCalifornia ~~Principal Executive Offices) (Zip Code)~~92614

~~Registrant’s telephone~~(Address ~~number,~~of ~~including~~Principal ~~area code: (702~~Executive Offices) ~~605-46-36~~

(323) 909-2866

Registrant’s telephone number, including area code:

______________________________________

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Item 45.01. ~~Change~~Changes in ~~Registrant’s~~Control ~~Certifying~~of ~~Accountants~~Registrant.

OnEffective ~~March~~May 0916, ~~2022~~2024, ~~the~~Gagi ~~Board~~Gogolashvili, the ofprevious ~~Directors~~sole officer and director and majority shareholder of Intorio, Corp. (the “Company”), ~~approved~~entered ~~the~~into ~~dismissal~~a ofstock ~~Zia~~purchase agreements ~~Masood~~for ~~Kiani~~the &sale Coof ~~(“ZMK”)~~2,000,000 ~~as the~~shares ~~Company’s~~of ~~independent~~Common ~~registered~~Stock ~~public~~of ~~accounting~~the ~~firm~~Company, ~~effective~~representing ~~immediately,~~approximately ~~and~~89% of the ~~engagement~~issued ofand ~~Victor~~outstanding shares ~~Mokuolu,~~of ~~CPA~~Common ~~PLLC (“Victor”)~~Stock asof the Company’s ~~new~~as ~~independent~~of ~~registered~~such ~~public~~date, ~~accounting~~to ~~firm~~six as(6) ofaccredited investors, and ~~for~~as ~~the~~such ~~year~~they ~~ended~~are ~~February~~able to unilaterally control ~~28,~~the ~~2022.~~election Asof ~~described~~our ~~below,~~board ~~the~~of ~~change~~directors, inall ~~independent~~matters ~~registered~~upon ~~public~~which ~~accounting~~shareholder ~~firm~~approval is ~~not~~required and, ultimately, the ~~result~~direction of ~~any disagreement with ZMK~~our Company.

~~ZMK’s~~Upon ~~audit~~the ~~report~~resignation ~~on the~~of ~~financial~~Mr. ~~statements~~Gogolashvili ~~for~~from all ~~the~~executive ~~year~~officer ~~ended~~positions ~~February~~with 28the Company, ~~2021~~including ~~did~~Chief ~~not~~Executive ~~provide~~Officer anand ~~adverse~~President, ~~opinion~~and oras ~~disclaimer~~a member of ~~opinion to~~ the ~~Company’s~~Board, effective ~~financial~~May ~~statements~~16, ~~nor~~2024, ~~modify~~Dr. ~~its~~Han-Wen ~~opinion~~Ou was appointed as toChief ~~uncertainty~~Executive Officer, ~~audit~~Chief ~~scope~~Financial orOfficer, ~~accounting~~Secretary ~~principles~~and sole Director.

~~During the fiscal year ended February 28, 2021 and February 28, 2022, there were: (i) no disagreements within the meaning of~~ Item ~~304(a)(1)(iv)~~5.02 ofDeparture ~~Regulation S-K and the related instructions between the Company and ZMK on any matters~~ of ~~accounting~~Directors ~~principles~~ or ~~practices,~~Principal ~~financial statement disclosure, or auditing scope or procedure which, if not resolved to ZMK’s satisfaction, would have caused ZMK to make reference thereto in its report~~Officers; ~~and~~Election ~~(ii) no “reportable events” within the meaning~~ of ~~Item~~Directors; ~~304(a)(1)(v)~~Appointment of ~~Regulation~~Principal ~~S-K, except that ZMK concurred with the Company’s assessment of material weaknesses related to the Company’s internal controls over financial reporting~~Officers.

~~During~~The ~~the~~disclosures ~~fiscal~~set ~~year~~forth ended February 28, 2022 and the subsequent interim period, neither the Company nor anyone on its behalf has consulted with Victor regarding: (i) the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company that Victor concluded was an important factor considered by the Company in ~~reaching a decision as to any accounting, auditing, or financial reporting issue; (ii) any matter that was the subject of a disagreement within the meaning of~~ Item ~~304(a)(1)(iv)~~5.01 ofabove ~~Regulation S-K and~~are ~~the~~incorporated ~~related~~by ~~instructions;~~reference orinto ~~(iii)~~this ~~any reportable event within the meaning of~~ Item ~~304~~5.02(a)~~(1)(v) of Regulation S-K~~.

The ~~Company~~business ~~provided~~background ~~ZMK~~descriptions ~~with a copy~~ of the ~~disclosures in this Form 8-K and requested that ZMK furnish the Company with a letter addressed to the Securities and Exchange~~newly ~~Commission~~appointed ~~(“SEC”),~~officer ~~stating whether it agrees with the statements made herein~~ and ifdirector ~~not, stating in what respects it does not agree. A copy of this letter, dated March 10, 2022,~~ is ~~filed~~ as ~~Exhibit 16.1 to this Form 8-K.~~follows:

~~Item~~Han-Wen ~~9.01.~~Ou ~~Financial~~- ~~Statements~~Chief Executive Officer and ~~Exhibits.~~Director

Exhibit No.		Description
16.1		Letter from Zia Masood Kiani & Co to the U.S. Securities and Exchange Commission, dated March 11, 2022.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

Dr. Ou has received the following degrees: a Bachelor of Science (BSc) from Taipei Medical University, a Master of Functional Medicine (MSc) from University of Western State (UWS), and a Doctor of Clinical Nutrition (PhD, DCN) from Maryland University of Integrative Health (MUIH).

2Dr. Ou was formerly a Resident at Taipei Veterans General Hospital (TVGH), and an Attending Physician of Family Medicine at Taipei City Hospital. He is currently Director of The American Academy of Anti-Aging Medicine (A4M) of Taiwan, China, and Singapore, Director of Chinese Functional Medicine Association (CFMA), Director of REDOX Integrative Functional Medicine Center and Director of REDOX Biomedicine CO., LTD.

~~SIGNATURES~~Item 8.01 Other Events.

~~Pursuant~~Change toin ~~the~~Address ~~requirements~~ of ~~the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~Company

	INTORIO, CORP.
Dated: March 11, 2022	By:	/s/ Gagi Gogolashvili
	Name:	Gagi Gogolashvili
	Title:	President, Director, CEO

Effective May 16, 2024, the Company’s location and the location of the Company’s books and records has changed from 24 Alexander Kazbegi Ave, Tbilisi 0177, Georgia, to 17875 Von Karman Avenue, Irvine, California 92614.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	INTORIO, CORP.

Dated: May 28, 2024	By:	/s/ Han-Wen Ou
	Name:	Han-Wen Ou
	Title:	CEO

Filing Compare · Redox International Group, Corp.